top of page
Xellera Therapeutics — Advancing Cell & Gene Therapy
In the rapidly evolving world of biotechnology, one name stands out for its commitment to groundbreaking innovation and high-quality manufacturing of advanced therapies: Xellera Therapeutics. Founded in 2018, Xellera is a CDMO (Contract Development & Manufacturing Organization) that offers end-to-end solutions for cell and gene therapy developers, helping accelerate the translation of life-changing treatments from concept to clinical reality.
Comprehensive Manufacturing & Development Services
Xellera’s CDMO platform provides a full suite of services for advanced therapy developers. Whether you’re moving from early experimental phases to regulated clinical trials or scaling production for commercial readiness, Xellera’s team supports critical steps.
Gallery
bottom of page